FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/03/017933 [Registered on: 06/03/2019] Trial Registered Prospectively
Last Modified On: 05/03/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Using markers of coronary artery disease to gain information about the disease 
Scientific Title of Study   Correlation of biomarkers with plaque rupture versus erosion in Acute Coronary syndromes: Optical Coherence Tomography based study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sreenivas Reddy 
Designation  Professor and Head 
Affiliation  Govt Medical College and Hospital, Chandigarh 
Address  Cardiology GMCH sector 32 Chandigarh

Chandigarh
CHANDIGARH
160047
India 
Phone    
Fax    
Email  reddycardio2911@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sreenivas Reddy 
Designation  Professor and Head 
Affiliation  Govt Medical College and Hospital, Chandigarh 
Address  Cardiology GMCH sector 32 Chandigarh

Chandigarh
CHANDIGARH
160047
India 
Phone    
Fax    
Email  reddycardio2911@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sreenivas Reddy 
Designation  Professor and Head 
Affiliation  Govt Medical College and Hospital, Chandigarh 
Address  Cardiology GMCH sector 32 Chandigarh

Chandigarh
CHANDIGARH
160047
India 
Phone    
Fax    
Email  reddycardio2911@gmail.com  
 
Source of Monetary or Material Support  
Govt Medical College and Hospital, Sector 32, Chandigarh - 160047. 
 
Primary Sponsor  
Name  ICMR 
Address  New Delhi 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S REDDY  Govt Medical College, Cardiology dept.  Sector 32
Chandigarh
CHANDIGARH 
9417495680

reddycardio2911@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC GMCH CHANDIGARH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I222||Subsequent non-ST elevation (NSTEMI) myocardial infarction,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1) Patients presenting with Acute Coronary syndromes (STEMI, NSTEMI, Unstable Angina with ≥10 minutes of angina or anginal equivalent consistent with unstable angina or myocardial infarction (MI) within 72 hours, with either elevated cardiac biomarkers (CK-MB or troponin) or ST-segment deviation of >1 mm in ≥2 contiguous electrocardiographic leads) to EMOPD or OPD of the Department of Cardiology at GMCH-32, will be included.  
 
ExclusionCriteria 
Details  1. Cardiogenic shock.
2. Left Ventricular Failure (Killip Class 3 or 4).
3. Serum creatinine ≥2.5 mg/dl.
4. Known allergy, hypersensitivity or contraindication to aspirin, heparin, or contrast.
5. Significant gastrointestinal or urinary bleed within the past 6 weeks, coagulopathy or bleeding diathesis.
6. Deranged LFTs like bilirubin >1.5mg/dl and enzymes 2 to 3 times elevated above upper limit of normal.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Association of biomarkers of inflammation with the type of plaque morphology.  30 days. 
 
Secondary Outcome  
Outcome  TimePoints 
Correlation of the systemic biomarkers of inflammation and the coronary blood biomarkers of inflammation.  30 days. 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

The aim of this study is to find the correlation biomarkers of inflammation with the plaque morphology, plaque rupture and plaque erosion detected on Intravascular Imaging by Optical Coherence Tomography in acute coronary syndrome patients and six months clinical outcomes. As the there is relative high incidence of CAD in India as compared to the western population, early diagnosis with biomarkers of the vulnerable plaque or the vulnerable patient will help initiating appropriate therapy and prevent acute coronary syndromes.

The biomarkers will help to assist in making management algorithms based on the biomarkers and its correlation with type of ACS. This helps to decide as to when to initiate the medical therapy or aggressive therapy based on the correlation of biomarkers

 
Close